← Back to headlines
First Human Trial of Anti-Aging Gene Therapy for Glaucoma Begins
An American company, Life Bioscience, has administered the first human dose of a gene therapy method aimed at reversing aging, specifically to rejuvenate the eyes of patients suffering from glaucoma.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
